Patients who need enteral tube feeding have historically used commercially prepared liquid enteral formulas, but an increasing number are opting for blended diets consisting of home-prepared foods or commercial thick formulas with real-food ingredients. The abstract notes a growing research base supporting this choice. A major practical barrier has been volume tolerance during transition and limitations of automated feeding pumps with thicker consistencies. The launch of the Kangaroo® OMNI™ Enteral Feeding Pump, designed to deliver thicker formulas and home-blended diets, is presented as a promising development to expand patient choice and support transitions to real-food enteral nutrition.
The source explains that while liquid commercial enteral formulas remain the conventional option, more patients are choosing blended diets or commercial thick formulas that include real-food ingredients. The abstract indicates that there is an expanding body of research that supports this movement toward real-food–based enteral nutrition, though the abstract itself does not provide the specific studies, methods, or quantified outcomes.
One practical challenge highlighted is volume tolerance when patients transition from standard liquid formulas to a real-food blended diet. Historically, blended diets were commonly administered by syringe bolus. The abstract notes that this route was frequently used because manufacturers indicated many automated feeding pumps could not cope with thicker consistencies. The abstract does not include detailed clinical protocols, definitions of volume tolerance thresholds, or patient selection criteria.
According to the abstract, prior to recent device developments, automated feeding pumps were generally stated by companies to be unsuitable for thicker consistencies. This limitation affected the administration options available to patients choosing a blended diet and often necessitated syringe bolus delivery. The abstract does not describe specific pump models, failure modes, or measured performance limitations.
The article highlights the introduction of the Kangaroo OMNI Enteral Feeding Pump, which is described as designed to deliver thick formula and home-blended diets. The abstract frames this as a potentially important advancement in enabling patients to use blended diets while maintaining automated pump-based delivery. The abstract does not provide technical specifications, clinical performance data, compatibility testing results, or comparative evaluations versus other pumps.
The abstract references a growing body of research that supports the choice of blended diets or commercial real-food–based formulas for some patients requiring enteral nutrition. However, the abstract does not report specific studies, outcomes, or levels of evidence. Important details—such as safety data, nutritional adequacy comparisons, infection risk, gastrointestinal tolerance metrics, or long-term outcomes—are not provided in this summary and therefore cannot be reported from this source.
From the abstract, clinicians and caregivers might infer key practical concerns when considering blended diets: the need to assess volume tolerance, decide on administration method (syringe bolus versus pump), and confirm device compatibility with thicker consistencies. The new Kangaroo OMNI pump is presented as intended to address device compatibility. Specific guidance on formulation standards, preparation methods, IDDSI levels, infection control measures, tube types and sizes, or stepwise transition protocols are not detailed in the abstract and are not available from this source.
This item is an article by Rhiannon Birkett (Lead Paediatric Haematology Oncology Pharmacist, Oxford University Hospitals NHS Foundation Trust) published in Br J Nurs (2026 Aug 6;35(15):780-786). Identifiers provided in the abstract include PMID 42555594 and DOI 10.12968/bjon.2026.0328. The abstract lists keywords including Blended diet, Bolus feeds, Enteral feeding, Enteral feeding pump, IDDSI, and Thick formulas. The conflict of interest statement in the abstract notes that the article was supported by Cardinal Health. The abstract does not report additional detailed conflict declarations beyond that support statement.
Note: This rewritten summary is limited to information contained in the abstract. Specific technical, clinical, or safety details about blended diet protocols, pump performance, or research outcomes were not reported in the source abstract and therefore are not included here.